ABDX.F Stock Overview
Operates as contract research, and contract development and manufacturing organization that develops, manufactures, and distributes diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Abingdon Health Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.07 |
| 52 Week High | UK£0.07 |
| 52 Week Low | UK£0.07 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 0% |
Recent News & Updates
Recent updates
Shareholder Returns
| ABDX.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | -0.7% | -2.1% |
| 1Y | n/a | 22.5% | 29.7% |
Return vs Industry: Insufficient data to determine how ABDX.F performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how ABDX.F performed against the US Market.
Price Volatility
| ABDX.F volatility | |
|---|---|
| ABDX.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.6% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: ABDX.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ABDX.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | n/a | Chris Henry Yates | www.abingdonhealth.com |
Abingdon Health Plc develops, manufactures, and distributes diagnostic devices worldwide. It offers AbC-19 Rapid Test, a COVID-19 IgG rapid antibody test; nucleic acid lateral flow immunoassays; Seralite, a rapid lateral flow test for the quantitative measurement of kappa and lambda immunoglobulin free light chains in serum; and AppDx, a customizable image capturing technology that transforms a smartphone into a self-sufficient and standalone lateral-flow reader. The company also provides lateral flow development and manufacturing services.
Abingdon Health Plc Fundamentals Summary
| ABDX.F fundamental statistics | |
|---|---|
| Market cap | US$9.40m |
| Earnings (TTM) | US$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs ABDX.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ABDX.F income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$0 |
| Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did ABDX.F perform over the long term?
See historical performance and comparison